Current status of pharmaceutical and genetic therapeutic approaches to treat DMD
Duchenne muscular dystrophy (DMD) is a genetic disease affecting about one in every 3,500 boys. This X-linked pathology is due to the absence of dystrophin in muscle fibers. This lack of dystrophin leads to the progressive muscle degeneration that is often responsible for the death of the DMD patien...
Hlavní autoři: | Pichavant, C, Aartsma-Rus, A, Clemens, P, Davies, K, Dickson, G, Takeda, S, Wilton, S, Wolff, J, Wooddell, C, Xiao, X, Tremblay, J |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2011
|
Podobné jednotky
-
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.
Autor: Pichavant, C, a další
Vydáno: (2011) -
Utrophin upregulation in DMD therapy: current status and new tools for the future
Autor: Fairclough, R, a další
Vydáno: (2011) -
DMD antisense oligonucleotide mediated exon skipping efficiency correlates with flanking intron retention time and target position within the exon
Autor: Remko Goossens, a další
Vydáno: (2023-12-01) -
BMP antagonists enhance myogenic differentiation and ameliorate the dystrophic phenotype in a DMD mouse model
Autor: SongTing Shi, a další
Vydáno: (2011-02-01) -
DMD and West syndrome
Autor: Cardas, R, a další
Vydáno: (2017)